Seminari E - Search Results

1

Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.

Castagna A, Galli L, Torti C, D'Arminio Monforte A, Mussini C, Antinori A, Cozzi-Lepri A, Ladisa N, De Luca A, Seminari E, Gianotti N, Lazzarin A. Castagna A, et al. Among authors: seminari e. Antivir Ther. 2010;15(2):165-75. doi: 10.3851/IMP1513. Antivir Ther. 2010. PMID: 20386071 Clinical Trial.

2

Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients.

Villani P, Regazzi MB, Castelli F, Viale P, Torti C, Seminari E, Maserati R. Villani P, et al. Among authors: seminari e. Br J Clin Pharmacol. 1999 Nov;48(5):712-5. doi: 10.1046/j.1365-2125.1999.00071.x. Br J Clin Pharmacol. 1999. PMID: 10594473 Free PMC article. Clinical Trial.

3

Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients.

Clerici M, Seminari E, Maggiolo F, Pan A, Migliorino M, Trabattoni D, Castelli F, Suter F, Fusi ML, Minoli L, Carosi G, Maserati R; Master Group. Clerici M, et al. Among authors: seminari e. AIDS. 2002 Sep 6;16(13):1767-73. doi: 10.1097/00002030-200209060-00009. AIDS. 2002. PMID: 12218388

4

Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.

Guffanti M, De Pascalis CR, Seminari E, Fusetti G, Gianotti N, Bassetti D, Galli A, Castagna A, Lazzarin A. Guffanti M, et al. Among authors: seminari e. AIDS. 2003 Dec 5;17(18):2669-71. doi: 10.1097/00002030-200312050-00017. AIDS. 2003. PMID: 14685066

5

Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.

Trabattoni D, Piconi S, Biasin M, Rizzardini G, Migliorino M, Seminari E, Boasso A, Piacentini L, Villa ML, Maserati R, Clerici M. Trabattoni D, et al. Among authors: seminari e. AIDS. 2004 Apr 9;18(6):859-69. doi: 10.1097/00002030-200404090-00003. AIDS. 2004. PMID: 15060433

6

Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients.

Hasson H, Gianotti N, Danise A, Seminari E, Boeri E, Nozza S, Castagna A, Lazzarin A. Hasson H, et al. Among authors: seminari e. AIDS. 2004 Jan 2;18(1):123-7. doi: 10.1097/00002030-200401020-00016. AIDS. 2004. PMID: 15090838

7

Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients.

Gianotti N, Seminari E, Fusetti G, Salpietro S, Boeri E, Galli A, Lazzarin A, Clementi M, Castagna A. Gianotti N, et al. Among authors: seminari e. AIDS. 2004 Nov 5;18(16):2205-8. doi: 10.1097/00002030-200411050-00016. AIDS. 2004. PMID: 15577657

8

Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.

Seminari E, Castagna A, Soldarini A, Galli L, Fusetti G, Dorigatti F, Hasson H, Danise A, Guffanti M, Lazzarin A, Rubinacci A. Seminari E, et al. HIV Med. 2005 May;6(3):145-50. doi: 10.1111/j.1468-1293.2005.00278.x. HIV Med. 2005. PMID: 15876279 Free article.

9

Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen.

Gianotti N, Seminari E, Lazzarin A, Boeri E, Clementi M, Danise A, Salpietro S, Fusetti G, Castagna A. Gianotti N, et al. Among authors: seminari e. AIDS Res Hum Retroviruses. 2005 Jun;21(6):545-54. doi: 10.1089/aid.2005.21.545. AIDS Res Hum Retroviruses. 2005. PMID: 15989459 Clinical Trial.

10

Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.

Gianotti N, Seminari E, Guffanti M, Boeri E, Villani P, Regazzi M, Bigoloni A, Schira G, Tiberi S, Fusetti G, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: seminari e. New Microbiol. 2005 Apr;28(2):119-25. New Microbiol. 2005. PMID: 16035256 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters